Improvement in enzyme activity of different mutant α-Gal A was shown in HEK293-transfected cells treated with either migalastat [21,63,64] or migalastat and ambroxol [65], the known pharmacological chaperone of glucocerebrosidase, deficient in Gaucher disease [66]. This evidence concerns the gene GBA1 and Gaucher disease.